Brain Advance Access published online on March 9, 2005
Brain, doi:10.1093/brain/awh467
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Radiology, University of California-San Francisco, San Francisco, USA
* To whom correspondence should be addressed. Summary Histopathological reports of multiple sclerosis and its animal models have shown evidence of a link between axonal injury in active lesions and impaired glutamate metabolism. Mature oligodendrocytes play a role in glutamate uptake to maintain glutamate homeostasis but in multiple sclerosis white matter the loss of expression of glutamate transporters in the lesion vicinity results in ineffective glutamate removal. Using a magnetic resonance spectroscopy technique that isolates the glutamate resonance at 3 T, we compared glutamate levels between normal subjects and multiple sclerosis patients in different brain areas. Metabolite concentrations (glutamate, glutamine, N-acetyl-aspartate, myo-inositol, choline, creatine) were derived from LCmodel and corrected for T1 relaxation time. Glutamate concentrations were found to be elevated in acute lesions (P = 0.02) and normal-appearing white matter (P = 0.03), with no significant elevation in chronic lesions (P = 0.77). The N-acetyl-aspartate level in chronic lesions was significantly lower (P < 0.001) than in acute lesions and normal-appearing white matter. The choline level in acute lesions was significantly higher (P < 0.001) than in chronic lesions. Evidence was also found for increased glial activity in multiple sclerosis, with significantly higher (P < 0.001) myo-inositol levels in acute lesions compared with control white matter. These in vivo results support the hypothesis that altered glutamate metabolism is present in brains of multiple sclerosis patients.
Received October 14, 2004
Revised January 3, 2005
Accepted February 1, 2005
Article
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T
2 GE Medical Systems, Menlo Park, CA, USA
3 Department of Neurology, University of California-San Francisco, San Francisco, USA
Radhika Srinivasan, E-mail: rsriniva{at}mrsc.ucsf.edu
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. E. Benarroch Oligodendrocytes: Susceptibility to injury and involvement in neurologic disease Neurology, May 19, 2009; 72(20): 1779 - 1785. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Centonze, L. Muzio, S. Rossi, F. Cavasinni, V. De Chiara, A. Bergami, A. Musella, M. D'Amelio, V. Cavallucci, A. Martorana, et al. Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune Encephalomyelitis J. Neurosci., March 18, 2009; 29(11): 3442 - 3452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Okuda, R. Srinivasan, J. R. Oksenberg, D. S. Goodin, S. E. Baranzini, A. Beheshtian, E. Waubant, S. S. Zamvil, D. Leppert, P. Qualley, et al. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures Brain, January 1, 2009; 132(1): 250 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Zahr, D. Mayer, A. Pfefferbaum, and E. V. Sullivan Low Striatal Glutamate Levels Underlie Cognitive Decline in the Elderly: Evidence from In Vivo Molecular Spectroscopy Cereb Cortex, October 1, 2008; 18(10): 2241 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.E. Gonsette Review: Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? Multiple Sclerosis, January 1, 2008; 14(1): 22 - 34. [Abstract] [PDF]
|
|
|
|
|
|
N. De Stefano, M. Filippi, D. Miller, P. J. Pouwels, A. Rovira, A. Gass, C. Enzinger, P. M. Matthews, and D. L. Arnold Guidelines for using proton MR spectroscopy in multicenter clinical MS studies Neurology, November 13, 2007; 69(20): 1942 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Centonze, M. Bari, S. Rossi, C. Prosperetti, R. Furlan, F. Fezza, V. De Chiara, L. Battistini, G. Bernardi, S. Bernardini, et al. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis Brain, October 1, 2007; 130(10): 2543 - 2553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.P. Wattjes, M. Harzheim, G.G. Lutterbey, L. Klotz, H.H. Schild, and F. Traber Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance Spectroscopy AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1517 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Domercq, M. V. Sanchez-Gomez, C. Sherwin, E. Etxebarria, R. Fern, and C. Matute System xc- and Glutamate Transporter Inhibition Mediates Microglial Toxicity to Oligodendrocytes J. Immunol., May 15, 2007; 178(10): 6549 - 6556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Sheehan, C. Zhou, I. Gravanis, A. D. Rogove, Y.-P. Wu, D. F. Bogenhagen, and S. E. Tsirka Proteolytic Activation of Monocyte Chemoattractant Protein-1 by Plasmin Underlies Excitotoxic Neurodegeneration in Mice J. Neurosci., February 14, 2007; 27(7): 1738 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Alonso, S. S. Jick, H. Jick, and M. A. Hernan Antibiotic Use and Risk of Multiple Sclerosis Am. J. Epidemiol., June 1, 2006; 163(11): 997 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Alberdi, M. V. Sanchez-Gomez, I. Torre, M. Domercq, A. Perez-Samartin, F. Perez-Cerda, and C. Matute Activation of kainate receptors sensitizes oligodendrocytes to complement attack. J. Neurosci., March 22, 2006; 26(12): 3220 - 3228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Caramanos, S. Narayanan, and D. L. Arnold 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review Brain, November 1, 2005; 128(11): 2483 - 2506. [Abstract] [Full Text] [PDF]
|
|